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Abstract
Chronic infection is associated with an increased risk of atherothrombotic disease and direct
bacterial infection of arteries has been suggested to contribute to the development of unsta-
ble atherosclerotic plaques. In this study, we examined coronary thrombi obtained in vivo
from patients with ST-segment elevation myocardial infarction (STEMI) for the presence of
bacterial DNA and bacteria. Aspirated coronary thrombi from 22 patients with STEMI were
collected during primary percutaneous coronary intervention and arterial blood control sam-
ples were drawn from radial or femoral artery sheaths. Analyses were performed using 16S
polymerase chain reaction and with next-generation sequencing to determine bacterial taxo-
nomic classification. In selected thrombi with the highest relative abundance of Pseudomo-
nas aeruginosa DNA, peptide nucleic acid fluorescence in situ hybridization (PNA-FISH)
with universal and species specific probes was performed to visualize bacteria within
thrombi. From the taxonomic analysis we identified a total of 55 different bacterial species.
DNA from Pseudomonas aeruginosa represented the only species that was significantly
associated with either thrombi or blood and was >30 times more abundant in thrombi than in
arterial blood (p<0.0001). Whole and intact bacteria present as biofilm microcolonies were
detected in selected thrombi using universal and P. aeruginosa-specific PNA-FISH probes.
P. aeruginosa and vascular biofilm infection in culprit lesions may play a role in STEMI, but
causal relationships remain to be determined.
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Introduction
Atherosclerosis (AS) is a chronic inflammatory disease, and vulnerable atherosclerotic plaques
can rupture or erode, which can result in luminal thrombus formation and critical end-organ
ischemia, e.g., stroke or myocardial infarction [1,2]. While a number of traditional risk factors
for AS, such as hypertension, dyslipidemia, diabetes mellitus, obesity, and smoking are well-
established, it is also widely accepted that other chronic inflammatory diseases (e.g., rheuma-
toid arthritis, psoriasis and chronic inflammatory bowel disease) and infectious diseases are
also independently associated with manifestations of AS [3–8]. Direct infection of the arterial
wall has also been proposed as a contributor to inflammatory plaque destabilization and
thrombotic complications [6, 9]. In particular, there is an increasing interest in the potential
role of periodontal pathogens in AS, e.g., Porphyromonas gingivalis, Prevotella intermedia and
Aggregatibacter actinomycetemcomitans [10–12]. However, many other infectious agents may
play a role in AS including Chlamydophila pneumoniae, Helicobacter pylori, cytomegalovirus,
influenza A virus, and Pseudomonas species [6, 13, 14].
While there are several reports on isolation of bacterial DNA from atherosclerotic tissue
only a few recent studies have detected bacterial biofilms within atherosclerotic lesions [6, 13,
15]. In biofilm infections, microcolonies of bacteria become encased in a protective extracellu-
lar matrix consisting mainly of polysaccharides, proteins and DNA [16, 17]. Biofilms are noto-
riously resistant to antibiotic treatment and host immune defenses, and can result in chronic
infections including, for example, wound infections, middle ear infections, foreign body-asso-
ciated infections, and periodontitis [16]. Coronary thrombi aspirated from patients with ST-
segment elevation myocardial infarction (STEMI) during primary percutaneous coronary
intervention (PCI) have also been demonstrated to contain bacterial DNA [18, 19]. In addi-
tion, the aspirated material contains fragments from the lipid rich plaques of culprit coronary
artery segments and PCI with thrombectomy can hence serve as a method of in vivo sampling
of coronary thrombus and plaque material [20]. STEMI which is typically manifested by acute
chest pain and characterized by STE in the patient’s electrocardiogram, is usually caused by
acute thrombotic occlusion of a major coronary artery and (if untreated) is associated with
considerable mortality and worsened long term prognosis.
In this study, we hypothesized that bacterial infection of coronary plaques, e.g. with oral
pathogens could be demonstrated by performing a microbiome study of coronary thrombi
aspirated from patients with STEMI, and that presence of intact bacteria, potentially in the
form of biofilms could be confirmed by microscopic examination. Since bacterial translocation
is likely to occur via circulating blood, we also collected arterial blood samples as controls. We
analyzed aspirated thrombi and arterial blood from patients with STEMI using next-genera-
tion sequencing to obtain taxonomic information on recorded DNA reads. In addition, we
examined thrombi with the highest relative abundance of Pseudomonas aeruginosa DNA with
peptide nucleic acid fluorescence in situ hybridization (PNA-FISH) with universal and P. aeru-
ginosa-specific 16S rRNA probes to detect intact bacteria and bacterial biofilms.
Materials and Methods
Participants
We enrolled 22 patients with STEMI referred to one tertiary cardiology center (Copenhagen
University Hospital, Rigshospitalet, Denmark) for primary PCI, and where thrombectomy was
performed at the discretion of the invasive cardiologist. Patients were excluded if they were
unable to give informed consent, e.g., due to cardiac arrest or cardiogenic shock, or if they pre-
sented with clinical and biochemical signs of active infection, e.g., fever, productive cough,
Pseudomonas aeruginosa in Coronary Thrombi
PLOS ONE | DOI:10.1371/journal.pone.0168771 December 28, 2016 2 / 13
and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
dysuria or visibly infected ulcers with markedly elevated C-reactive protein (CRP) levels and
leucocyte counts. Also, patients were excluded if they had received systemic antibiotics, or/and
immunocompromising treatment, e.g., chemotherapy or immunosuppressive treatment
within a period of three months prior to admission. Baseline characteristics were recorded and
periodontal status was assessed by interview and a standardized questionnaire which generally
has acceptable validity in determining periodontal health [21]. The interview included ques-
tions regarding number of remaining teeth, frequency of gum bleeding during oral hygiene,
and periodontal disease diagnosed by a dentist. Self-reported periodontal disease was only reg-
istered, if the patient reported that their dentist at the latest visit prior to the STEMI had
informed him/her of the presence of periodontitis.
The study was approved by The Regional Committee on Health Research Ethics of The
Capital Region of Denmark (protocol number H-2-2012-154), and written informed consent
was given by all participants.
Sample collection
The thrombi were sampled during primary PCI using standard thrombectomy catheters
(Export1 AP Aspiration Catheter, Medtronic, Minneapolis, MN, USA). Each thrombus was
aspirated into a sterile syringe, and the content was emptied into the collecting basket supplied
by the manufacturer. Here, the material was rinsed with heparin and retrieval of solid frag-
ments was visually confirmed. The collecting basket was then immediately placed in a sterile
container, sealed, labeled, and frozen at -80˚C until analysis. An arterial blood sample was
drawn from the femoral (n = 17) or radial (n = 5) artery sheath, transferred into a heparinized
collection tube and stored with the thrombus sample.
16S polymerase chain reaction and next-generation sequencing
The samples were thawed on ice, and all handling was done in laminar flow bench using sterile
equipment. Once thawed, each thrombus was cut in two sections: One section was placed in a
10% formalin solution for fixation before paraffin casting. The second piece was mechanically
homogenized in 50 μL molecular grade water (Sigma-Aldrich, St. Louis, MO, USA), and trans-
ferred directly as template into a pre-prepared polymerase chain reaction (PCR) tube contain-
ing ready master mix. Similarly, the thawed arterial blood from the same patient was pipetted
into 50 μL molecular grade water, vortexed and transferred to a different PCR tube with identi-
cal PCR master mix. Using high precision weighing (Sartorius ED scale, Sartorius, Go¨ttingen,
Germany) the weight of each thrombus before homogenization was registered. Comparable
amounts of blood and thrombus could then be analyzed by pipetting 1 μL blood per 1 μg of
thrombus. A nested PCR protocol was followed using primers annealing to the bacterial 16S
rRNA gene. Master mix for both the first and second reaction consisted of Phusion Blood
Direct Master Mix (Thermo Fisher Scientific, Waltham, MA, USA) which contained buffer
solution with dNTP mix, proofreading Blood Direct Polymerase II enzyme stable to inhibitors
in blood, and 0.25 μM reaction specific primers. For the first reaction, the primers used were
337F (5’- TCC TAC GGG AGG CAG C-3’) and 1391R (5’- GAC GGG CGG TGT GTR CA-
3’). The thermo-cycle protocol included 5 min denaturing at 98˚C followed by 30 cycles of 5
sec denaturation at 98˚C, 5 sec annealing at 63˚C, and 15 sec extension at 72˚C. Final exten-
sion was at 72˚C for 1 min. Debris was pelleted using tabletop centrifugation and the superna-
tant from the first PCR product was used in a 1:100 dilution as template for the second
reaction. For the second reaction, the PCR primer pair was 515F (5’-GTG CCA GCM GCC
GCG GTA A-3’) and 806R (5’-GGACTA CHV GGG TWT CTA AT‘-3). The same thermo-
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cycle protocol was used for the second reaction but with annealing temperature 58˚C for 15
cycles. Mock PCRs were used as true negative controls.
Sequencing of PCR products was performed by Beijing Genomics Institute that was blinded
to the samples and provided DNA purification, amplicon library preparation (16S v4) and
sequencing performed on Illumina PE300 MiSeq System (Illumina, San Diego, CA, USA)
according to standardized guidelines [22].
PNA-FISH
The five thrombi (male n = 3, female n = 2) with the highest relative abundance of P. aerugi-
nosa DNA were analyzed with PNA-FISH. Each formalin-preserved thrombus piece was cast
in paraffin. From the paraffin cast, six 2 μm thick serial sections were cut and placed on two
microscope slides with three sections on each slide. One slide was incubated with a P. aerugi-
nosa specific 16S PNA-FISH probe and the other with a universal 16S PNA-FISH probe. The
samples were deparaffinated according to standard protocol (Xylene 2 x 5 min, 99.9% EtOH 2
x 3 min, 96.5% EtOH 2 x 3 min, MilliQ 3 x 3 min) and incubated with PNA-FISH probe for 90
min at 56˚C [23]. The probes used were a fluorescent TexasRed (TXR) conjugated universal
bacterial 16S rRNA probe (BacUni CP0054TxR, AdvanDx, Woburn, MA, USA) and a fluores-
cent TXR conjugated P. aeruginosa-specific 16S rRNA probe (P. aeruginosa ref. 102307TxR,
AdvanDx, Woburn, MA, USA). After incubation with PNA-FISH probes, the samples were
counterstained with a 3 μM DAPI-solution (4’,6-diamidino-2-phenylindole [DAPI], Thermo
Fisher Scientific, Waltham, MA, USA) for 15 min at room temperature and finally rinsed with
PBS, air-dried and fixated with antifade mountant (ProLong1Gold antifade reagent, Life tech-
nologies, Eugene, OR, USA) [23]. The slides were examined using confocal laser scanning
microscopy (LSM780, Zeiss Microscopy, Oberkochen, Germany). Objective used for imaging
was 63x/1.4 Oil. Software for processing was Zen Lite version 2.3 (Zeiss Microscopy, Oberko-
chen, Germany).
Data analysis
Sequences were clustered to operational taxonomic units (OTUs) at 97% sequence similarity
and taxonomic ranks were assigned to OTU representative sequences using the Ribosomal
Database Project (RDP) [24]. Subsequently, the sequences were blasted against two different
16S reference databases (Greengenes and Human Oral Microbiome Database [HOMD]) for
genus and species specific identification [25, 26]. Alpha diversity was compared between the
two sample groups (thrombi versus arterial blood) using Chao-index, Shannon-index, and
Simpsons-index. Comparison of relative abundance at genus- and species level was performed
using Mann-Whitney U test with Benjamini Hochberg correction for multiple comparisons.
Software R version 3.0.3 was used as statistical software, and Graphpad Prism version 7and
MultiExperiment Viewer version 4.9 were used as graphic software.
Results
Patient characteristics
The baseline characteristics are shown in Table 1. The study included 22 patients with STEMI
who underwent thrombectomy during primary PCI. Mean age was 61±11.5 years and 73% of
patients were male (Table 1). Smoking and hypertension were the most prevalent cardiovascu-
lar risk factors (both reported in 59% of patients), and 47% of patients reported known peri-
odontal disease (Table 1). All patients were discharged after an uneventful in-hospital course.
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General findings from next-generation sequencing
For each of the 22 thrombi and 22 arterial blood samples, bacterial rDNA was amplified by the
use of PCR. Four thrombus samples failed quality control prior to next-generation sequencing
due to degradation or low DNA concentration (<5 ng/μL), and these thrombi and their corre-
sponding blood samples were therefore excluded. Thus, DNA from a total of 36 samples (18
thrombi with corresponding arterial blood) was successfully sequenced, from which a mean of
23,316 (range 17,468–28,136) sequences were generated with an approximate length of 250bp.
A mean of 88.5% (range 67.2%–97.1%) of these sequences passed subsequent library quality
control and were eligible for further analysis [22].
Comparable microbial diversity in thrombus and blood samples
Using 97% similarity as cutoff, a total number of 210 different OTUs were identified with a
mean of 29 (range 10–89) OTUs per sample (Figure A in S1 File). No statistical difference was
Table 1. Baseline characteristics of ST-segment elevation myocardial infarction study population.
Patients with STEMI (n = 22)
Age, years, mean±SD 61±11.5
Sex, male/female, % 73/27
Hypertension, % 59
Hypercholesterolemia, % 32
Diabetes mellitus, % 5
Smoking, active or previous, % 59
Previous MI, % 14
Family history of IHD, % 41
CRP, mg/L, median (IQR)* 4 (1.2)
WBC, x109/L, median (IQR)* 11 (3.6)
TnT max, ng/L, median (IQR) 4600 (6350)
LVEF† (n = 19), n
>45% 14
30–45% 3
<30% 2
Coronary artery culprit vessel, %
LAD 41
LCx 50
RCA 9
Periodontal status (n = 19)‡, %
Self-reported PD 47
Edentulism 16
Regular gum bleeding 32
STEMI, ST-segment elevation myocardial infarction; SD, standard deviation; IHD, ischemic heart disease;
CRP, C-reactive protein; IQR, interquartile range; WBC, white blood cell count; TnT, troponin T; LVEF, left
ventricular ejection fraction; LAD, left anterior descending artery; LCx, left circumflex artery; RCA, right
coronary artery; PD, periodontal disease.
*CRP and WBC at time of admittance.
†LVEF at time of discharge.
‡Periodontal status was assessed at 11±3 months post-discharge, at which time 1 patient had died and 2
were unavailable for follow-up.
doi:10.1371/journal.pone.0168771.t001
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observed in the mean number of OTUs between thrombus (mean OTU = 28) and blood sam-
ples (mean OTU = 30).
Alpha diversity was tested by means of Chao-index, Shannon-index and Simpson’s diver-
sity index, which all demonstrated similar diversities in both thrombi and blood (Figure B in
S1 File).
High relative abundance of DNA from P. aeruginosa in thrombus
samples
Based on the Greengenes annotation 90% of sequences could be identified at genus level with a
total number of 96 bacterial genera identified (Table A in S1 File). The predominant genera
identified were Achromobacter and Pseudomonas, corresponding to approximately 45% of
total identifications at genus level (Figure C in S1 File). When blasted against the Greengenes
database, only 10% of sequences could be identified at species level. Blast against the HOMD
database resulted in identification at the genus level of 78% of sequences representing 54 dif-
ferent bacterial genera (Table B in S1 File). Achromobacter, Pseudomonas, Sphingomonas, Ste-
notrophomonas and Burkholderia were the predominant bacterial genera identified and
accounted for 66% of the total bacterial identifications at genus level. The 10 most predomi-
nant genera and their relative abundance in thrombi and arterial blood samples are presented
in Fig 1. Based on the HOMD annotation, 71% of generated sequences could be assigned at
species level. A total number of 55 different bacterial species were identified with a mean of 14
(range 8–34) different species per sample (Table C in S1 File). The 10 most predominant spe-
cies are shown in Fig 1. The dataset containing information on the numbers of DNA reads per
identified species in each of the analyzed samples is available in the supporting information
(S1 Dataset).
DNA from P. aeruginosa was detected in 18/18 thrombi with a mean of 5,563 (range 671 to
19,101) reads per thrombus which represented 28% of DNA from all species (mean 19,670
reads per thrombus) identified in the thrombi. In the arterial blood samples, DNA from P. aer-
uginosa was detected in 12/18 samples, but 7 of these 12 had only minute ( 5) number of
reads. Overall, DNA from P. aeruginosa represented 0.9% of all species identified in the arterial
blood samples (mean 179 [range 0–2,123] of 19,585 total reads). Accordingly, for P. aeruginosa
both the relative abundance of DNA and the absolute number of DNA reads were >30 times
higher in thrombi than in arterial blood (p<0.0001). In thrombi, DNA from Achromobacter
xylosoxidans was detected in high amounts in both the thrombi and arterial blood samples and
was not significantly associated with either thrombi or blood. In 10/18 patients, A. xylosoxidans
constituted >20% of species-identified DNA in both thrombus and arterial blood from each
patient. Remarkably, in 6/8 of the remaining patient samples, A. xylosoxidans constituted
<0.001% of species-identified DNA in both thrombus and blood.
No significant correlation was found between self-reported periodontal disease, regular
gum bleeding, or edentulism, respectively, and the relative abundance of A. xylosoxidans, P.
aeruginosa or any other detected species.
PNA-FISH results
Images from the confocal laser scanning examination with PNA-FISH of 5 selected thrombi
with the highest relative abundance of P. aeruginosa DNA are shown in Fig 2. The examined
thrombi measured approximately 2–3 mm on their long axis. Inflammatory cells, primarily
polymorphonuclear leukocytes (PMNs) were abundant in the thrombi. Using the universal
16S rRNA probe, 2 of the 5 thrombi showed presence of bacterial microcolonies containing
rod-shaped bacteria. The microcolonies measured up to 20 μm in diameter (Fig 2). Using a
Pseudomonas aeruginosa in Coronary Thrombi
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probe specific for P. aeruginosa, bacteria were found in small clusters of about 5 μm in diame-
ter in 1 of the 5 thrombi (Fig 2).
Discussion
In this study we examined thrombi aspirated from culprit coronary lesions of patients with
STEMI, and arterial blood control samples, with use of next-generation sequencing to deter-
mine the bacterial taxonomy, and PNA-FISH to investigate the presence of intact bacteria and
bacterial biofilm. We found that both thrombi and arterial blood samples contained DNA
from several bacterial species. Alpha diversity analyses showed comparable diversities in both
thrombi and blood. However, P. aeruginosa was significantly more abundant (ratio >30:1,
p<0.0001) in thrombi than in blood.
Furthermore, microscopic examination of selected thrombi with universal and P. aerugi-
nosa-specific PNA-FISH probes demonstrated microcolonies of intact bacteria. To the best of
our knowledge, no previous microbiome study of coronary thrombi obtained in vivo has been
conducted, and this is the first study to demonstrate high relative abundance of P. aeruginosa
DNA and bacterial microcolonies within coronary thrombi.
The role of infection in AS and its clinical manifestations including myocardial infarction
has been debated for decades. Early studies have focused on infectious agents such as C. pneu-
moniae and H. pylori, but it remains to be determined if such agents are partners in crime, or
merely innocent bystanders in the atherothrombotic process. Several large randomized con-
trolled trials have been conducted using antibiotics (primarily targeting C. pneumoniae) for
secondary prevention in patients with established atherosclerotic disease, but outcomes have
Fig 1. Predominant bacterial genera (A) and species (B) in aspirated coronary thrombi and arterial
blood from patients with ST-segment elevation myocardial infarction. Data were based on Human Oral
Microbiome Database (HOMD) annotation.
doi:10.1371/journal.pone.0168771.g001
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been mostly negative [27]. Also, a number of contemporary studies have focused on microor-
ganisms involved in periodontal disease, and while no direct causal link with any specific oral
pathogen has been determined, evidence suggests that periodontal disease is an independent
risk factor for atherothrombotic disease [4, 10, 11, 19]. Indeed, presence of DNA from peri-
odontal bacteria in aspirated coronary thrombi from patients with STEMI determined by PCR
has previously been reported, but these studies used a limited range of oligonucleotide primers
for typical oral pathogens only (i.e., not for P. aeruginosa) and to our knowledge, next genera-
tion sequencing and PNA-FISH data from aspirated coronary thrombi from patients with
STEMI are not available [18, 19].
To examine an association between specific pathogens and coronary artery thrombosis, we
analyzed the DNA sequencing results from aspirated thrombi using both a general and an oral
microbiome-specific 16S database (Greengenes and HOMD, respectively). Findings on genus
level were very similar with use of both databases and Achromobacter, Pseudomonas, Sphingo-
monas, and Stenotrophomonas were the predominant genera. The HOMD annotation yielded
the highest level of species identification, and all species detected in this study are thus micro-
organisms that have been isolated from the human oral cavity [26]. Interestingly, none of the
typical bacteria believed to be involved in more aggressive periodontal disease, e.g., A. actino-
mycetemcomitans and red complex bacteria (P. gingivalis, Treponema denticola, Tannerella for-
sythia) were identified in any of the samples. However, no specific pathogens are universally
associated with periodontitis, and microbial composition of biofilms related to periodontal
Fig 2. Confocal laser scanning microscopy images with PNA-FISH showing microcolonies of bacteria detected in coronary thrombi. Confocal
laser scanning microscopy images with Peptide nucleic acid fluorescence in situ hybridization (PNA-FISH) of aspirated coronary thrombi from patients
with STEMI. A: Magnified image of hybridization with a TexasRed (TXR) conjugated universal 16S rRNA probe and 4’,6-diamidino-2-phenylindole (DAPI)
counterstaining showing microcolonies of rod-shaped bacteria (arrows). Miniature overview with DAPI counterstaining in lower left corner with marked (□)
approximate area of interest. B: Magnified image with TexasRed (TXR) conjugated P. aeruginosa specific 16S rRNA probe and DAPI counterstaining.
Miniature overview with DAPI counterstaining in lower left corner with marked (□) area of interest. Cluster of P. aeruginosa (arrow 1) and adjacent red
blood cells (arrow 2). Display characteristics were adjusted to automatic Best Fit for red and blue color channels. Magnification with 63x/1.4 Oil objective.
doi:10.1371/journal.pone.0168771.g002
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disease may differ considerably in composition from individual to individual and may also
change over time [28]. Indeed, a previous study demonstrated that the oral microbiome of
patients with chronic periodontitis only sporadically contained DNA from traditional peri-
odontal pathogens, i.e., P. gingivalis and A. actinomycetemcomitans [28]. In that study, A.
xylosoxidans was also found in the oral microbiome of patients with periodontitis [28]. Inter-
estingly, in our study DNA from A. xylosoxidans was highly abundant in both coronary
thrombi and arterial blood samples from 10/18 patients, but in the majority of the remaining
patients, A. xylosoxidans constituted <0.001% of the species-specific DNA in both thrombi
and blood. This strong association between the presence or absence of A. xylosoxidans in
thrombi and blood, respectively, suggests that the bacteria had translocated from elsewhere
(oral or other microbiomes and/or the environment) via circulating blood to atherothrombo-
tic plaques. However, no significant correlation was observed between the presence of any
detected bacterial species and self-reported periodontal disease, regular gum bleeding, or eden-
tulism, respectively.
P. aeruginosa can be observed as part of the commensal microbiome of the oral cavity, gut,
and skin in healthy humans [26, 29–32]. Though P. aeruginosa is not considered a typical path-
ogen in periodontal disease, P. aeruginosa has been demonstrated to be associated with the
oral microbiome of patients with chronic periodontitis [29].
P. aeruginosa is a widespread rod-shaped, bacillus common to soil, moist environments,
and hospitals where it is a typical opportunistic pathogen in nosocomial infections [16, 33]. P.
aeruginosa and other Pseudomonas species have previously been isolated from human athero-
sclerotic tissue, and chronic infection with P. aeruginosa has been shown to exacerbate AS in a
hypercholesterolemic rat model [13, 14, 34–36]. P. aeruginosa is highly adaptive and versatile
and is prototypical of a multidrug-resistant organism [37]. A key component in the resistance
of P. aeruginosa to both antibiotics and the immune system of the infected host is its ability to
form biofilm [16]. In the form of biofilms, P. aeruginosa evades the phagocytic activity of
PMNs by launching a lethal shield of the toxin di-rhamnolipid that rapidly lyses incoming
PMNs [38, 39]. This releases inflammatory mediators, metallo-proteases, oxygen radicals, and
extracellular DNA, that all contribute to increased inflammation and antibiotic resistance [40,
41]. Interestingly, a recent study of human carotid artery plaques revealed Pseudomonas spe-
cies as well as bacterial biofilms within the atherosclerotic vessel wall [13]. In this study, it was
also demonstrated that P. aeruginosa biofilms undergo dispersion when challenged with physi-
ologically relevant concentrations of norepinephrine [13]. Since biofilm dispersion involves
release of degradative enzymes and transition to higher bacterial growth rates this may destabi-
lize arterial plaques and provide a mechanistic link between the hormonal stress state and risk
of atherothrombotic events [13]. The presence of biofilms in atherosclerotic plaques may also
explain, in part, why trials of antibiotics have failed in patients with AS as biofilms are highly
resistant to systemic antibiotic therapy [16, 17, 27]. In addition to matrix-degrading proteases
and di-rhamnolipid toxin, P. aeruginosa displays an impressive arsenal of other virulence fac-
tors including the potent exotoxin A, which, similarly to diphtheria toxin, inhibits protein syn-
thesis of host cells and may remain cytotoxic long after the bacteria have been killed [16, 32].
Also, pyocyanin, a P. aeruginosa virulence factor important for quorum sensing and biofilm
colonization, can elicit apoptosis of erythrocytes with phosphatidylserine externalization creat-
ing a procoagulant erythrocyte phenotype and contributing to a prothrombotic microenviron-
ment [32, 42]. Taken together, our current analyses of aspirated coronary thrombi from
patients with STEMI therefore considerably expand the accumulating evidence that P. aerugi-
nosa and biofilms can play a pathogenic role in development of atherothrombotic plaques and
their clinical manifestations.
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Some limitations apply to the results of this study, especially the small sample size, the lack of
oral examination and individual mapping of oral microbiomes of patients, and the inherent lim-
itations of the applied analytical techniques. Importantly, our DNA sequencing data were sup-
ported by the PNA-FISH results. Although we did not confirm bacterial viability with culture
experiments, the recording of distinct fluorescent signals in biofilm-like aggregates are highly
suggestive of viable bacteria, since only live cells contain intact rRNA that enables probe-hybrid-
ization. Moreover, our PNA-FISH examination was limited by the availability of thrombus
material, i.e. only approximately half of the each thrombus was cast in paraffin (the rest was
DNA-amplified and sequenced) and only three serial 2 μm thick sections of each thrombus
were examined with universal and P. aeruginosa specific 16S probes, respectively. Therefore, we
believe that the extent of P. aeruginosa microcolonies in thrombi may have been underesti-
mated. Of note, although the diameter of detected aggregates did not exceed 20 μm in our study,
biofilm have generally been defined as bacterial aggregates as small as 5 μm in diameter [17].
In conclusion, we observed that DNA from P. aeruginosa was significantly more abundant
in aspirated coronary thrombi than in arterial blood from patients with STEMI. Microcolonies
of bacteria were detected within thrombi in biofilm-like aggregates. The role of P. aeruginosa
infection and biofilms in atherothrombotic coronary culprit lesions of patients with STEMI
warrants further study.
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